IMS Health (IMS) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- BofA lifts targets on AMD and ARM, raises CPU TAM to $170bn
IMS Health Reports First-Quarter 2016 Results
May 3, 2016 6:15 AM EDTRevenue up 25.2 percent at constant currency Adjusted EBITDA up 9.4 percent at constant currency Adjusted Net Income up 6.4 percent at constant currency Adjusted Diluted Earnings per Share was $0.42 reported, up 9.5 percent at constant currency Constant currency guidance reaffirmed, reported guidance raised
DANBURY, Conn.--(BUSINESS WIRE)-- IMS Health Holdings, Inc. (IMS Health) (NYSE: IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced... More
IMS Health and Quintiles to Merge; Quintiles IMS to Become Industry-Leading Information and Technology-Enabled Healthcare Service Provider
May 3, 2016 6:00 AM EDTAll-stock transaction with combined 2015 revenue of $7.2 billion and combined equity market capitalization of $17.6 billion
Broad range of healthcare information, technology and services solutions to drive efficiencies and insights across the entire life sciences product lifecycle, from R&D through commercial execution to real-world patient outcomes. Capabilities to address mission-critical healthcare operations with a market opportunity of more than $230 billion. Quintiles IMS will: Accelerate patient access to innovative medicines by increasing the productivity of the $100 billion spent on drug development Demonstrate the value... MoreIMS Health and Quintiles to Merge
May 3, 2016 6:00 AM EDTQuintiles IMS to Become Industry-Leading Information and Technology-Enabled Healthcare Service Provider
All-Stock Transaction with Combined 2015 Revenue of $7.2 Billion and Combined Equity Market Capitalization of $17.6 Billion
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IMS Health Holdings, Inc. (NYSE: IMS) and Quintiles Transnational Holdings Inc. (NYSE: Q):
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160503005889/en/
... More